[vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ width=”1/1″ tablet_text_alignment=”default” phone_text_alignment=”default”][vc_column_text]”Spotlight: Welton Investment Corporation”
CTA Intelligence
July 2014[/vc_column_text][/vc_column][/vc_row][vc_row type=”in_container” full_screen_row_position=”middle” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ width=”1/1″ tablet_text_alignment=”default” phone_text_alignment=”default”][text-with-icon icon_type=”font_icon” icon=”icon-quote-left” color=”Accent-Color”]From physician to institutional investment manager, Welton Investment Corp founder and CEO Pat Welton reveals the secrets of his firm’s performance turnaround and its next moves into quant equities and the ’40 Act space. [/text-with-icon][text-with-icon icon_type=”font_icon” icon=”icon-quote-left” color=”Accent-Color”]For two years, the firm dedicated over half of its research budget – a budget representing two-thirds of the firm’s overall budget – to two ambitious initiatives to fundamentally improve its intellectual property (IP) and allocation platform.[/text-with-icon][/vc_column][/vc_row]

Author

Welton Investment Partners